METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Clinical trials for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new drug called tuvusertib, given together with either lartesertib or avelumab, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see how the body pr…
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a new drug called tuvusertib, given alone or with another drug (niraparib), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and see early signs of tumor…
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC